CVD EQUIPMENT CORP
For the period ended Dec 31, 2024. Filed Mar 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 19, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 11. Executive Compensation
| Item 11. | Executive Compensation. |
|---|
Summary Compensation Table
The following table sets forth the compensation of our chief executive officer and chief financial officer, and our “named executive officers,” for the years ended December 31, 2024 and 2023.
| Name and principal position | Year | Salary ($) | Bonus ($) (1) | Option Awards ($) (2) | Stock Awards ($) (2) | All Other Compensation ($) (3) | Total ($) |
|---|---|---|---|---|---|---|---|
| Emmanuel Lakios | 2024 | 415,000 | - | - | - | 20,744 | 435,744 |
| President and Chief Executive Officer | 2023 | 388,600 | - | 699,990 | - | 19,522 | 1,108,112 |
| Richard Catalano Secretary, Chief | 2024 | 283,800 | - | - | - | 26,772 | 310,572 |
| Financial Officer and Executive Vice President | 2023 | 274,700 | - | 233,330 | - | 27,201 | 535,231 |
| Jeffrey A. Brogan | 2024 | 206,000 | 25,000 | - | - | 7,578 | 238,578 |
| Vice President Sales & Marketing | 2023 | 203,300 | - | 139,998 | - | 7,863 | 351,161 |
| (1) | Reflects cash bonuses under the Company’s Management Bonus Plan. Bonuses listed for a particular year represents amounts earned with respect to such year even though all or part of such amounts have been paid during the following year. |
| (2) | These columns represent the grant date fair value of the stock awards as calculated in accordance with FASB ASC 718 (Stock Compensation). The stock options granted in 2023 vest 25% per year over four years and have a ten-year life. There were no stock options granted in 2024 to the named executive officers |
| (3) | All other compensation consists of 1) 401(k) match in 2024 and 2023 of $10,350 and $9,900 for Emmanuel Lakios, $8,514 and $9,179 for Richard Catalano, and $6,930 and $7,863 for Jeffrey Brogan, respectively; and 2) health, life and disability insurance premiums in 2024 and 2023 of $10,394 and $9,622 for Emmanuel Lakios, $18,258 and $18,022 for Richard Catalano and $0 and $648 for Jeffrey Brogan. |
Employment Agreements and Potential Payments Upon Termination or Change in Control
Emmanuel Lakios Employment Agreement
On June 1, 2021, the Company entered into an Employment Agreement with Emmanuel Lakios, the Company’s President and Chief Executive Officer (the “Lakios Agreement”). The term of Mr. Lakios’s employment under the Lakios Agreement commenced as of the effective date thereof and shall continue until terminated in accordance with the terms of the Lakios Agreement. Under the Lakios Agreement, Mr. Lakios will receive an initial annual base salary of $288,000, which shall be reviewed from time to time and may be increased, but not decreased, by the Compensation Committee of the Board of Directors (the “Committee”) in its sole and exclusive discretion. Mr. Lakios shall be entitled to participate in any bonus or incentive plan available to the Company’s senior executives generally, on such terms as the Committee may determine in its discretion.
In the event of the termination of the Lakios Agreement and Mr. Lakios’s employment thereunder, Mr. Lakios or his estate (in the event of his death) shall be entitled to (A) receive any unpaid base salary earned and accrued under the Lakios Agreement prior to the date of termination (and reimbursement for expenses incurred prior to the date of termination), (B) indemnification in accordance with any applicable indemnification plan, program, corporate governance document or other arrangement, and any vested rights pursuant to any insurance plan, benefit plan or retirement plan, and, except in the event of Mr. Lakios’s termination by the Company for Cause (as defined in the Lakios Agreement), (C) treatment of his stock option grants in accordance with the terms of the applicable plan and award agreement.
In the event Mr. Lakios’s employment is terminated as a result of death or disability, Mr. Lakios shall also be entitled to receive a pro rata bonus payment under the Company’s bonus Plan for the year of termination, if applicable.
In the event Mr. Lakios’s employment is terminated by the Company for Cause, Mr. Lakios’s stock option grants, whether vested or unvested, shall immediately terminate and be null and void.
In the event Mr. Lakios’s employment is terminated by the Company without Cause, or by Mr. Lakios for Good Reason (as defined in the Lakios Agreement), Mr. Lakios shall also be entitled to (A) a pro rata bonus for the year of termination, and (B) continued payment of his base salary and the Company’s portion of Mr. Lakios’s then existing medical benefits for the nine (9) month period following the date of termination.
The Lakios Agreement contains customary non-competition, non-solicitation, and confidentiality provisions in favor of the Company.
Other then as set forth above, there are no arrangements for compensation of directors or Named Executive Officers and there are no employment contracts between the Company and its directors or any change in control arrangements.
Equity Awards
From time to time, we grant equity awards, including stock options, to our employees, including our named executive officers. Historically, we have typically granted new-hire option awards on, or within the calendar quarter of, a new hire's employment start date and annual refresh employee option grants in the first quarter of each fiscal year, which refresh grants are typically approved at a regularly scheduled meeting of the Compensation Committee occurring in such quarter. Also, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board and at the time of each annual meeting of our stockholders, respectively, pursuant to our non-employee director compensation policy, as further described under the heading, “2024 Director Compensation” below.
We do not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. The Compensation Committee considers whether there is any material nonpublic information (“MNPI”) about our company when determining the timing of stock option grants and doesnot seek to time the award of stock options in relation to our public disclosure of MNPI. We havenot timed the release of MNPI for the purpose of affecting the value of executive compensation.
During fiscal 2024, the Company did not grant any equity awards to its named executive officers.
Outstanding Equity Awards at December 31, 2024
The following table sets forth the outstanding equity awards held by our named executive officers as of December 31, 2024.
| OPTION AWARDS | STOCK AWARDS | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Name · Number of Securities Underlying Options Exercisable · Number of Securities Options Unexercisable · Exercise Price · Option Expiration Date · Number of shares or units of stock that have not vested · Market value of shares or units of stock that have not vested · Equity Incentive Plan Awards: Number of unearned shares or units that not vested · Equity Incentive Plan Awards: Market or payout value of unearned shares or units that have not vested | |||||||||
| Emmanuel Lakios | 18,750 | 56,250 | $14.11 | 3/23/2033 | - | - | - | $ | - |
| 37,500 | 37,500 | $5.02 | 8/17/2032 | ||||||
| 75,000 | 25,000 | $4.26 | 6/1/2031 | ||||||
| 100,000 | - | $10.30 | 2/6/2027 | ||||||
| Richard Catalano | 6,250 | 18,750 | $14.11 | 3/23/2033 | - | - | - | $ | - |
| 10,000 | 10,000 | $5.42 | 8/30/2032 | ||||||
| Jeffrey A. Brogan | 3,750 | 11,250 | $14.11 | 3/23/2033 | - | - | - | $ | - |
| 7,500 | 7,500 | $5.02 | 8/17/2032 | ||||||
| 15,000 | 5,000 | $4.01 | 7/15/2021 | ||||||
| 20,000 | - | $11.61 | 10/31/2027 | ||||||
2024 Director Compensation
The following table sets forth a summary of the compensation we paid to our non-employee directors in 2024.
| Name | Fees Earned or Paid in Cash | Option Awards | Restricted Stock Awards | Total |
|---|---|---|---|---|
| Lawrence J. Waldman | $113,000 | - | $40,000 | $153,000 |
| Robert M. Brill | 50,000 | - | 40,000 | 90,000 |
| Debra Wasser | 40,000 | - | 40,000 | 80,000 |
| Ashraf Lotfi | 42,500 | - | 40,000 | 82,500 |
| Andrew Africk | 23,736 | - | 23,738 | 47,474 |
| Raymond A. Nielsen | 30,435 | - | 40,000 | 70,435 |
On October 11, 2021, the Board of Directors, following the unanimous recommendation of the Board’s Compensation Committee, unanimously approved a director compensation plan, effective October 1, 2021 (the “Plan”). The Plan is based on the recommendations of an independent compensation consultant engaged by the Board’s Compensation Committee. Pursuant to the Plan, each director is entitled to Director Compensation, divided into the following pay components: (i) Annual Board of Directors cash compensation in the amount of $40,000 and (ii) an annual equity retainer in the amount of $40,000, to be automatically granted on the date of the Company’s annual meeting of shareholders. Additionally, a director serving as a chairman for the Board’s Compensation Committee or Nominating, Governance and Compliance Committee is entitled to annual chair compensation in the amount of $10,000. The director serving as the chairman for the Board’s Audit Committee is entitled to chair compensation in the amount of $25,000. Furthermore, the director serving as the Non-Executive Chairman is entitled to Board leadership compensation in the amount of $48,000.
Raymond A. Nielsen retired from the Board of Directors on August 9, 2024 and Andrew Africk was appointed to the Board of Directors on May 28, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.